arrow
A

Aileen Y. Chang

George Washington University
H指数:23
被引数:1,908

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Low-Dose Interleukin-2 Enhances Activated Suppressor Regulatory T Cells and CTLA-4 and HLA-DR Expression in Chronic Chikungunya Arthritis

低剂量白介素-2增强慢性奇坎农病毒性关节炎中活化抑制性调节T细胞及CTLA-4和HLA-DR的表达

2026-09-080
OA
Vaccines, Bias, and the Perils of Non-peer-reviewed Studies: Fueling Misinformation and Vaccine Hesitancy

疫苗、偏见与非同行评审研究的危害:助长错误信息与疫苗犹豫

2026-08-050
OAAI
New Perspectives in Prevention, Control, and Treatment of Dengue Fever

登革热预防、控制和治疗的新视角

2026-01-010
OA
Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE)

登革热临床试验核心结局测量集:一项国际德尔菲共识研究(DEN-CORE)

2025-10-070
PRE
The role of autoantibodies in post-chikungunya viral arthritis disease severity
2025-03-010
OAAI
Dengue NS1 Antibodies Are Associated With Clearance of Viral Nonstructural Protein-1
2024-06-061
OAAI
Regulatory T-cells and GARP expression are decreased in exercise-associated chikungunya viral arthritis flares
2022-10-073
OAAI
Clinical evaluation of the BioFire Global Fever Panel for the identification of malaria, leptospirosis, chikungunya, and dengue from whole blood: a prospective, multicentre, cross-sectional diagnostic accuracy study
2022-09-0114
OAAI
A Dengue Vaccine: Will It be Accepted and Is It Feasible? Lessons from Barranquilla, Colombia, and Merida, Venezuela

登革热疫苗: 会被接受吗?可行吗?哥伦比亚巴兰基亚和委内瑞拉梅里达的经验教训

2019-10-162
OAAI
Chronic Joint Pain 3 Years after Chikungunya Virus Infection Largely Characterized by Relapsing-remitting Symptoms
2019-07-0149
OAAI